Skip to main content

Find Clinical Trials

Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,056 public trials 1,845 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Not yet recruiting

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases

NCT06483672

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of Lung Metastatic to Brain, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

NCT06462105

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

NCT06475755

Conditions: Anti Angiogenesis, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Tangdu Hospital of the Fourth Millitary Medical University Xi'an, Shaanxi, China

View Trial Details

Not yet recruiting

Understanding Lung Cancer Related Risk Factors and Their Impact

NCT06473870

Conditions: Lung Cancer Screening, Lung Diseases, Lung Neoplasms, +5 more
Locations: Centre Hospitalier Universitaire de Liège Liège, Wallonia, Belgium

Riga East University Hospital Riga, Latvia

Hospital Universitario Cruces Barakaldo, Viscay, Spain

Hospital Universitario Virgen Macarena Seville, Spain

View Trial Details

Not yet recruiting

Efficacy and Safety of Multimode Thermal Therapy in the Treatment of Early Peripheral Lung Cancer

NCT06453889

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

NCT06454890

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.

NCT06452433

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

NCT06434740

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC

NCT06436144

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy

NCT06422637

Conditions: Liquid Biopsy for Early Screening of Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College Guangzhou, Guangdong, China

View Trial Details